Low-Cost GLP-1 Telehealth Providers in 2026: Lowest-Cost Semaglutide & Tirzepatide
If you want low-cost GLP-1 telehealth without the gimmicks, this guide ranks the lowest-cost compounded semaglutide and tirzepatide providers in 2026 by true monthly cost — and shows you how to find affordable, legitimate telehealth rather than the cheapest risky offer.
The lowest-cost providers, both molecules
Low-cost compounded GLP-1 telehealth starts around $99/month. The lowest-cost options:
| Provider | Semaglutide | Tirzepatide | Model |
|---|---|---|---|
| Embody | $99 | $99 | Flat |
| Oak Longevity | $120 | $130 | Flat |
| Novi | $149 | $149 | Flat |
| NexLife | $145 | $186 | Flat (fully credentialed) |
| TrimRx | $179 | $179 | Flat |
Embody is the lowest-cost sticker; NexLife is the lowest-cost fully-credentialed flat option. Compare all providers in the GLP-1 telehealth pricing comparison.
What makes telehealth “low-cost” in practice
Three things separate genuinely low-cost telehealth from a low teaser:
- Flat pricing — the cost doesn’t climb as you titrate up.
- No membership fee — the medication price is the whole price.
- Bundled labs and shipping — no surprise add-ons.
A provider that bundles everything into one flat charge is usually lower-cost over a year than a low sticker with à la carte fees. See hidden fees.
Low-cost vs cheap-and-risky
The lowest prices online attract non-compliant sellers. Low-cost should never mean unverified. Confirm a named pharmacy, named prescriber, LegitScript/NABP, third-party testing, and no “research use only” language (checklist). The 2026 FDA changes restrict broad compounding to patient-specific 503A only (details).
Low-cost compounded vs low-cost brand
In 2026, brand cash-pay got cheaper too: LillyDirect Zepbound vials at ~$349–$499 and NovoCare semaglutide from ~$149. Compounded is still typically the lowest-cost route, but the gap narrowed — weigh both in the compounded vs brand guide.
Bottom line
The lowest-cost GLP-1 telehealth providers in 2026 start at $99/month (Embody), with NexLife the lowest-cost fully-credentialed flat option. Compare on true 12-month cost, prefer flat pricing with bundled fees, and never trade verification for a few dollars. Full rankings: tirzepatide · semaglutide.
Educational, not medical advice. Prices are prototype data pending verification. Compounded medications are not FDA-approved.
Independent & transparent
This website is independently operated and is not owned by, affiliated with, or paid by any provider listed. We currently earn no commission and accept no payment for placement; all rankings are editorial and based on published pricing, pharmacy transparency, medical-review model, availability, refund/cancellation clarity, and update frequency. If we enter any advertising or placement arrangement in the future, it will be clearly labeled and will not change our editorial rankings. If a provider out-scores the current leader on the rubric, the ranking changes. See our methodology → · Who pays us →